HopeStage
Back to all studies
RecruitingNCT07559500

How tirzepatide affects brain dopamine in people with alcohol use disorder

About this titleRead the official source — NCT07559500
Medication studyAges 21–65United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 21 years to 65 years.

What will I do during this study?

The study has two parts. In Part 1, five healthy volunteers have two or three PET/MRI (magnetic resonance imaging) visits two to three weeks apart, including tracer and methylphenidate procedures. In Part 2, participants are randomly assigned to tirzepatide or placebo (an inactive comparison treatment) and receive two injections one week apart, with PET and functional MRI assessments. These parts involve different participant groups and procedures.

Listed locations
BethesdaSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 20, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
176
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 21 Years to 65 Years
Official registry ID
NCT07559500
Official title
Show the full official title

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD), a Phase 1b Study

Recruitment & locations

Currently recruiting

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), a research institute.

Does this study involve medication?

Yes. The study involves medication, including Tirzepatide, Placebo, [11C]raclopride plus drug and [11C]NNC-112.

Who can participate?

Listed age limits: 21 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies